Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
32 hedge funds and large institutions have $19.5M invested in Streamline Health Solutions in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
33% more capital invested
Capital invested by funds: $14.7M → $19.5M (+$4.78M)
10% more funds holding
Funds holding: 29 → 32 (+3)
0.66% more ownership
Funds ownership: 1.58% → 2.24% (+0.66%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$7.38M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$95.3K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$47.2K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$43.4K |
| 5 |
VF
Virtu Financial
New York
|
+$23.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$255K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$54.7K |
| 3 |
JIC
Johnson Investment Counsel
Cincinnati,
Ohio
|
-$51K |
| 4 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$32K |
| 5 |
Renaissance Technologies
New York
|
-$17.8K |
STRM Hedge Fund Activity: Q3 2022 in Review
32 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q3 2022, worth a combined $19.5M — up 33% from $14.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new STRM positions and 4 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Tamarack Advisers, opening a new position worth an estimated $7.38M. The largest seller was Punch & Associates Investment Management, cutting an estimated $255K.
- 32 institutional investors held Streamline Health Solutions (STRM) as of Q3 2022, up from 29 in Q2 2022.
- Funds reported $19.5M of Streamline Health Solutions stock for Q3 2022, up 33% quarter-over-quarter.
- 7 funds opened new Streamline Health Solutions positions in Q3 2022 and 4 closed out, a net change of +3 holders.
- The largest Streamline Health Solutions buyer in Q3 2022 was Tamarack Advisers, an estimated $7.38M added.
- The largest Streamline Health Solutions seller in Q3 2022 was Punch & Associates Investment Management, an estimated $255K sold.
Based on aggregated 13F filings for Q3 2022.